Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-25 @ 2:08 PM
NCT ID:
NCT01189266
Group ID:
EG001
Title:
Arm 2 Phase 1 Vorinostat 230 mg/m^2
Description:
Patients received a higher dose of vorinostat at 230 mg/m\^2/day PO on Monday through Friday weekly for the duration of radiation therapy (6-7 weeks). Patients underwent 3D conformal or intensity-modulated radiation therapy 5 days per week for 6 weeks. After completing concurrent vorinostat and radiation therapy, patients then received maintenance therapy comprising of vorinostat at 230 mg/m\^2/day PO on days 1-28. Treatment repeats every 28 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.
3-Dimensional Conformal Radiation Therapy: Undergo 3D conformal radiation therapy
Intensity-Modulated Radiation Therapy: Undergo intensity-modulated radiation therapy
Laboratory Biomarker Analysis: Correlative studies
Vorinostat: Given PO
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
6
Other Number Affected:
6
Other Number At Risk:
6
Study:
NCT01189266
Results Section:
NCT01189266
Adverse Events Module:
NCT01189266